Illumina
Illumina was founded in 1998. Our mission at Illumina is to improve human health by unlocking the power of the genome.
Illumina are a global genomics and human health leader innovating the future of precision health.
We develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health.
Our products enable researchers in academic, government, healthcare and commercial settings to comprehensively understand the genome and how it translates into health and disease.
Illumina’s technologies empower healthcare providers to leverage those genomic insights in clinical care, providing patients with diagnoses and groundbreaking therapies.
Our technologies are used to address life’s biggest health challenges including cancer, rare genetic diseases, infectious diseases like COVID-19, food insecurity and climate change.
Our commitment to life-changing discovery and better health is driven by our passion for continual innovation and deep collaboration. Our actions are guided by these five principles:
• Redefining possible
• Leading purposeful advances
• Broadening impact with collaboration
• Acting with integrity to benefit humanity
• Accelerating access.
Links to educational resources and events
Resources and Tools
Next Generation Sequencing for Beginners
Advantages of Next Generation Sequencing
NGS Methods and Applications
WGS - Shortening the Diagnostic Pathway
Shortening the Diagnostic Odyssey
Shortening the Diagnostic Pathway for Genetic Diseases
WGS - One approach, effective insights